|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 47.50 EUR | -3.81% |
|
-7.32% | -12.28% |
| Dec. 15 | BofA maintains its buy rating on Eramet, with a target price of €64 | |
| Dec. 09 | Oddo BHF Maintains Negative Stance on Eramet Despite Raised Target |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 0.41 | 7.43 | 11.55 | 0.14 | 0.48 | |||||
Return on Total Capital | 0.64 | 12.4 | 20.11 | 0.22 | 0.71 | |||||
Return On Equity % | -51.29 | 68.99 | 51.96 | 0.57 | -2.52 | |||||
Return on Common Equity | -62.44 | 83.36 | 64.16 | 6.09 | 0.92 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 63.62 | 74.07 | 70.7 | 67.04 | 67.91 | |||||
SG&A Margin | 52.14 | 45.42 | 39.53 | 55.78 | 54.69 | |||||
EBITDA Margin % | 8.69 | 27.57 | 29.5 | 7.31 | 9.48 | |||||
EBITA Margin % | 1.89 | 21.4 | 25.03 | 1.5 | 2.74 | |||||
EBIT Margin % | 1.14 | 20.32 | 24.26 | 0.45 | 1.62 | |||||
Income From Continuing Operations Margin % | -18.83 | 21.32 | 18.23 | 0.36 | -1.72 | |||||
Net Income Margin % | -18.8 | 8.03 | 14.5 | 3.26 | 0.46 | |||||
Net Avail. For Common Margin % | -18.8 | 19.51 | 17.56 | 3.08 | 0.46 | |||||
Normalized Net Income Margin | -0.22 | 11.35 | 16.97 | 11.91 | 2.95 | |||||
Levered Free Cash Flow Margin | 5.67 | 13.96 | 7.77 | -12.5 | -20.71 | |||||
Unlevered Free Cash Flow Margin | 7.98 | 15.88 | 9.07 | -9.81 | -17.2 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.58 | 0.58 | 0.76 | 0.5 | 0.48 | |||||
Fixed Assets Turnover | 1.51 | 1.64 | 2.21 | 1.45 | 1.16 | |||||
Receivables Turnover (Average Receivables) | 10.01 | 10.15 | 13.48 | 11.02 | 13.39 | |||||
Inventory Turnover (Average Inventory) | 1.3 | 1.3 | 2.3 | 1.64 | 1.48 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.3 | 1.45 | 1.58 | 1.7 | 1.64 | |||||
Quick Ratio | 1.65 | 0.86 | 0.98 | 1.13 | 0.94 | |||||
Operating Cash Flow to Current Liabilities | 0.2 | 0.3 | 0.39 | 0.1 | -0.08 | |||||
Days Sales Outstanding (Average Receivables) | 36.57 | 35.97 | 27.08 | 33.12 | 27.33 | |||||
Days Outstanding Inventory (Average Inventory) | 280.81 | 281.34 | 158.82 | 222.61 | 247.08 | |||||
Average Days Payable Outstanding | 164.11 | 272.16 | 91.92 | 159.23 | 145.31 | |||||
Cash Conversion Cycle (Average Days) | 153.27 | 45.15 | 93.98 | 96.5 | 129.09 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 320.26 | 158.28 | 89.26 | 111.68 | 104.07 | |||||
Total Debt / Total Capital | 76.21 | 61.28 | 47.16 | 52.76 | 51 | |||||
LT Debt/Equity | 291.47 | 123.15 | 65.39 | 80.54 | 88.03 | |||||
Long-Term Debt / Total Capital | 69.36 | 47.68 | 34.55 | 38.05 | 43.14 | |||||
Total Liabilities / Total Assets | 84.62 | 78.62 | 68.64 | 68.23 | 66.91 | |||||
EBIT / Interest Expense | 0.31 | 6.61 | 11.68 | 0.1 | 0.29 | |||||
EBITDA / Interest Expense | 2.53 | 9.12 | 14.37 | 1.83 | 1.79 | |||||
(EBITDA - Capex) / Interest Expense | 1.99 | 6.76 | 9.74 | -2.31 | -2.12 | |||||
Total Debt / EBITDA | 9.5 | 2.03 | 1.32 | 8.47 | 7.3 | |||||
Net Debt / EBITDA | 3.98 | 0.9 | 0.22 | 2.32 | 4.25 | |||||
Total Debt / (EBITDA - Capex) | 12.05 | 2.74 | 1.94 | -6.71 | -6.18 | |||||
Net Debt / (EBITDA - Capex) | 5.05 | 1.22 | 0.33 | -1.84 | -3.6 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -3.16 | 31.84 | 37.52 | -34.54 | -9.4 | |||||
Gross Profit, 1 Yr. Growth % | -5.27 | 41.14 | 31.26 | -37.93 | -8.22 | |||||
EBITDA, 1 Yr. Growth % | -44.19 | 104.19 | 47.12 | -83.79 | 17.62 | |||||
EBITA, 1 Yr. Growth % | -77.56 | 208.95 | 60.83 | -96.08 | 66 | |||||
EBIT, 1 Yr. Growth % | -85.3 | 227.83 | 64.19 | -98.79 | 226.67 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 366.21 | -594.38 | 17.57 | -98.71 | -533.33 | |||||
Net Income, 1 Yr. Growth % | 266.85 | -144.15 | 148.32 | -85.27 | -87.16 | |||||
Normalized Net Income, 1 Yr. Growth % | -112.97 | 314.39 | 105.64 | -54.06 | -77.6 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 267.17 | -520.77 | 22.19 | -88.52 | -86.18 | |||||
Accounts Receivable, 1 Yr. Growth % | -3.87 | 7.76 | -1.6 | -40.11 | -1.81 | |||||
Inventory, 1 Yr. Growth % | -17.49 | -36.31 | 25.48 | -14.5 | 11.79 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -13.59 | 5.17 | -0.99 | 0.35 | 25.8 | |||||
Total Assets, 1 Yr. Growth % | 8.38 | -3.1 | 14.67 | -12.33 | 3 | |||||
Tangible Book Value, 1 Yr. Growth % | -67.31 | 112.1 | 135.68 | -9.67 | -13.22 | |||||
Common Equity, 1 Yr. Growth % | -45.35 | 39.59 | 75.99 | -10.16 | -9.94 | |||||
Cash From Operations, 1 Yr. Growth % | 259.3 | 108.09 | 54.12 | -82.64 | -172.67 | |||||
Capital Expenditures, 1 Yr. Growth % | -83.25 | 313.85 | 82.53 | 21.18 | 11.76 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -226.3 | 41.97 | -23.46 | -205.33 | 50.04 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -442.75 | 31.9 | -21.47 | -170.8 | 58.83 | |||||
Dividend Per Share, 1 Yr. Growth % | - | - | 40 | -57.14 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -2.14 | 0.04 | 34.65 | -5.12 | -22.99 | |||||
Gross Profit, 2 Yr. CAGR % | 49.06 | 6.76 | 36.11 | -9.74 | -24.52 | |||||
EBITDA, 2 Yr. CAGR % | -35.97 | 35.28 | 73.32 | -51.16 | -56.33 | |||||
EBITA, 2 Yr. CAGR % | -63.38 | 61.88 | 122.91 | -74.91 | -74.51 | |||||
EBIT, 2 Yr. CAGR % | -70.92 | 64.39 | 132 | -85.9 | -80.11 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 137.35 | 133.56 | 141.09 | -87.68 | -76.35 | |||||
Net Income, 2 Yr. CAGR % | 256.87 | 27.26 | 4.7 | -39.52 | -86.25 | |||||
Normalized Net Income, 2 Yr. CAGR % | -81.25 | 165.48 | 191.92 | -2.8 | -67.92 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 273.04 | 90.77 | 126.74 | -62.55 | -87.41 | |||||
Accounts Receivable, 2 Yr. CAGR % | -6.14 | 1.78 | 2.97 | -23.23 | -23.31 | |||||
Inventory, 2 Yr. CAGR % | -2.19 | -27.51 | -10.61 | 3.58 | -2.23 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -1.76 | -4.67 | 2.04 | -0.32 | 12.36 | |||||
Total Assets, 2 Yr. CAGR % | 3.98 | 2.17 | 5.41 | 0.26 | -4.98 | |||||
Tangible Book Value, 2 Yr. CAGR % | -48.21 | -21.98 | 123.77 | 45.91 | -11.46 | |||||
Common Equity, 2 Yr. CAGR % | -31.03 | -14.92 | 56.73 | 25.74 | -10.05 | |||||
Cash From Operations, 2 Yr. CAGR % | -15.91 | 173.44 | 79.08 | -48.28 | -64.48 | |||||
Capital Expenditures, 2 Yr. CAGR % | -51.27 | -20.35 | 174.84 | 48.72 | 16.38 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 14.07 | 79.3 | 4.24 | -10.21 | 25.71 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 15.59 | 165.45 | 1.77 | -25.43 | 6.04 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | - | - | -22.54 | -34.53 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 0.36 | -0.35 | 11.23 | 5.88 | -6.57 | |||||
Gross Profit, 3 Yr. CAGR % | 30.28 | 38.78 | 14.37 | 4.77 | -9.23 | |||||
EBITDA, 3 Yr. CAGR % | -25.65 | 10.36 | 39.12 | -21.32 | -34.54 | |||||
EBITA, 3 Yr. CAGR % | -50.33 | 16.13 | 61.53 | -42.06 | -52.89 | |||||
EBIT, 3 Yr. CAGR % | -57.28 | 15.84 | 64.33 | -59.75 | -59.8 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 44.94 | 87.5 | 85.8 | -57.83 | -59.64 | |||||
Net Income, 3 Yr. CAGR % | 49.26 | 77.82 | 59.03 | -45.54 | -63.92 | |||||
Normalized Net Income, 3 Yr. CAGR % | -69.51 | 24.07 | 143.81 | 57.61 | -40.41 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 53.58 | 139.82 | 64.44 | -16.12 | -73.14 | |||||
Accounts Receivable, 3 Yr. CAGR % | -1.22 | -1.72 | 0.64 | -14.04 | -16.67 | |||||
Inventory, 3 Yr. CAGR % | 2.19 | -15.22 | -12.96 | -11.92 | 6.25 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 4.68 | 0.49 | -3.46 | 1.47 | 7.72 | |||||
Total Assets, 3 Yr. CAGR % | 2.08 | 1.36 | 6.18 | -0.87 | 1.17 | |||||
Tangible Book Value, 3 Yr. CAGR % | -38.05 | -20.65 | 12.85 | 65.38 | 22.71 | |||||
Common Equity, 3 Yr. CAGR % | -23.31 | -14.27 | 8.41 | 30.19 | 12.5 | |||||
Cash From Operations, 3 Yr. CAGR % | -23.38 | 13.74 | 125.87 | -17.74 | -42.07 | |||||
Capital Expenditures, 3 Yr. CAGR % | -32.99 | -3.46 | 5.01 | 109.19 | 35.21 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -20.35 | 49.06 | 35.01 | 4.6 | 6.55 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -14.13 | 40.05 | 76.88 | -9.82 | -4.06 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | 60.91 | - | - | -15.66 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 3.55 | 4.66 | 7.51 | -2.28 | -3.98 | |||||
Gross Profit, 5 Yr. CAGR % | 51.2 | 37.26 | 28.41 | 16.85 | -3.14 | |||||
EBITDA, 5 Yr. CAGR % | 49.34 | 31.62 | 14.67 | -20.35 | -12.48 | |||||
EBITA, 5 Yr. CAGR % | -26.27 | 124.25 | 18.14 | -37.08 | -22.82 | |||||
EBIT, 5 Yr. CAGR % | -34.57 | 113.49 | 18.67 | -50.1 | -29.38 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -5.67 | 27.8 | 33.18 | -36.9 | -18.54 | |||||
Net Income, 5 Yr. CAGR % | -1.12 | 10.73 | 29.52 | 15.51 | -40.26 | |||||
Normalized Net Income, 5 Yr. CAGR % | -41 | 76.62 | 25.92 | 12.53 | 8.33 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -1.24 | 30.05 | 34.41 | 14.11 | -41.16 | |||||
Accounts Receivable, 5 Yr. CAGR % | 3.86 | 2.59 | 0.44 | -10.97 | -9.73 | |||||
Inventory, 5 Yr. CAGR % | -0.67 | -8.43 | -3.14 | -8.15 | -8.82 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 0.85 | 3.27 | 3.62 | 0.17 | 2.58 | |||||
Total Assets, 5 Yr. CAGR % | 5.01 | 1.21 | 3.28 | 0.92 | 1.57 | |||||
Tangible Book Value, 5 Yr. CAGR % | -21.84 | -12.23 | 0.89 | 1.27 | 2.41 | |||||
Common Equity, 5 Yr. CAGR % | -12.22 | -7.75 | 1.01 | -0.07 | 0.61 | |||||
Cash From Operations, 5 Yr. CAGR % | 88.45 | 45.68 | 7.6 | -17.01 | 7.77 | |||||
Capital Expenditures, 5 Yr. CAGR % | -20.74 | 4.88 | 15.78 | 14.75 | 9.42 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 51.5 | 58.37 | -0.31 | 21.71 | 31.21 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 84.94 | 138.57 | 0.44 | 8.84 | 44.14 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | - | 8.76 | 20.11 | - |
- Stock Market
- Equities
- ERA Stock
- Financials Eramet
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















